An 18-year-old cisgender woman who acquired HIV at birth presents to her HIV primary care provider for routine follow-up. She is taking an antiretroviral regimen of tenofovir alafenamide-emtricitabine plus darunavir-cobicistat. Recent laboratory studies showed a CD4 count of 512 cells/mm3 and an undetectable HIV RNA level. A little more than one year ago, she became sexually active with a single male partner. She has completed the human papillomavirus (HPV) vaccine series.
According to the 2021 STI Treatment Guidelines and the HIV Adult and Adolescent Opportunistic Infection Guidelines, what are the recommendations for cervical cancer screening in women diagnosed with HIV prior to 21 years of age?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 26th, 2022
October 26th, 2022
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME+MOC
4
Give Feedback
Complete survey
5